Zobrazeno 1 - 10 of 14 pro vyhledávání: '"Rachelle, Hamadi"'
1
Akademický článek
Tumour-to-tumour metastasis: a rare case of prostate cancer metastasising to primary lung adenocarcinoma
Autor: Rachelle Hamadi, Imad Karam, Salman Khan, Sylvester Homsy, Carol Luhrs
Publikováno v: European Journal of Case Reports in Internal Medicine (2024)
Tumour-to-tumour metastasis (TTM) is a rare phenomenon that clinicians should be aware of when evaluating patients with a history of prostate cancer. We present the diagnosis and management of an 80-year-old former smoker with high-risk prostate canc
Externí odkaz: https://doaj.org/article/2fa7c5b9f6844a5d9c3378abac6a2c0b
Zobrazit plný text záznamu
2
Akademický článek
Heparin-Induced Thrombocytopenia in Chronic Hemodialysis Patients
Autor: Rachelle Hamadi MD, Fouad Sakr MD, Hussam Aridi MD, Zakaria Alameddine MD, Reem Dimachkie MD, Marc Assaad MD, Samer Asmar MD, Suzanne ElSayegh MD
Publikováno v: Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
Heparin-induced thrombocytopenia (HIT) is a disorder originating from exposure to heparin and has a spectrum of presentation ranging from asymptomatic positive antibodies to thrombotic complications. When symptomatic, it is associated with morbidity
Externí odkaz: https://doaj.org/article/f9af2aa342b2448190e42de54fb86f9a
Zobrazit plný text záznamu
4
Outcomes of Patients with Monoclonal Gammopathy of Undetermined Significance with and without Atrial Fibrillation: A Retrospective Cohort Analysis of the Nationwide Inpatient Sample Database
Autor: Skouri, Rachelle Hamadi, Zakaria Alameddine, Samer Asmar, Fouad Sakr, Hussam Aridi, Reem Dimachkie, Hadi
Publikováno v: Journal of Clinical Medicine; Volume 12; Issue 13; Pages: 4436
Background: Monoclonal gammopathy of undetermined significance (MGUS) is a non-malignant precursor of multiple myeloma (MM). MGUS has been suggested to be associated with a higher risk of cardiovascular diseases, including AFIB, but it is still uncle
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=multidiscipl::817c94290e9d59441c16f437c36377a9
Zobrazit plný text záznamu
5
Statin Use in Patients With Chronic Liver Disease and Cirrhosis: Current Evidence and Future Directions
Autor: Malek, Kreidieh, Rachelle, Hamadi, Mira, Alsheikh, Hassan, Al Moussawi, Liliane, Deeb
Publikováno v: Gastroenterology Research. 15:1-12
Chronic liver disease (CLD) and its complications constitute a significant cause of mortality and morbidity worldwide. Most deaths are secondary to the decompensation of cirrhosis and evolution of portal hypertension (PHTN). Since disease progression
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9e3e7a1b42b856abde83c2787bc4092
https://doi.org/10.14740/gr1498
Zobrazit plný text záznamu
10
Predictors of Deep Venous Thrombosis in Hospitalized Patients With Liver Cirrhosis in the US
Autor: Ahmad Abou Yassine, Mohammad Abureesh, Rachelle Hamadi, Loai Dahabra, Mohammad Alshami, Deeb Liliane
Publikováno v: Cureus. 14(3)
Background Patients with liver cirrhosis were previously considered as anticoagulated; thus, their risk of developing venous thromboembolism (VTE) is lower. Recently, several studies showed contradicting results regarding deep venous thrombosis (DVT)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b1375ef3a7ac5c184e4b0f7934ec5fa
https://pubmed.ncbi.nlm.nih.gov/35494982
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje